Evidence map›Paper›PMID 39850135›Full record

ArticleFrontiers in microbiology2024

Novel silver nanoparticle-based biomaterials for combating

Eslam Elashkar, Rihaf Alfaraj, Ola M El-Borady, Mahmoud M Amer, Abdelazeem M Algammal, Azza S El-Demerdash

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eslam ElashkarDepartment of Botany and Microbiology, Faculty of Science, Benha University, Benha, Egypt.
Rihaf AlfarajDepartment of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Ola M El-BoradyInstitute of Nanoscience and Nanotechnology, Kafrelsheikh University, Kafr ElSheikh, Egypt.
Mahmoud M AmerDepartment of Botany and Microbiology, Faculty of Science, Benha University, Benha, Egypt.
Abdelazeem M AlgammalDepartment of Bacteriology, Immunology, and Mycology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt.
Azza S El-DemerdashLaboratory of Biotechnology, Department of Microbiology, Agricultural Research Center, Animal Health Research Institute, Zagazig, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Antimicrobial susceptibility testing was performed to assess the antibiotic resistance profile of Results: The majority of Conclusion: This study highlights the synergistic effect of silver nanoparticles, chitosan, and sodium fluoride in combating

Indexed as

antibiofilm potentialchitosancytotoxicityKlebsiella pneumoniaesilver nanoparticlessodium fluoride

Identifiers

PMID39850135
PMCPMC11754292

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.